Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxybutynin for sertraline-induced sweating in depression
IRCT201101045547N1Phase 3Completed
- Sponsor
- Hamedan University of Medical Sciences
- Start
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of oxybutynin in hyperhidrosis and major depressive disorder (MDD), sponsored by Hamedan University of Medical Sciences. Started Dec 2010; status: completed.
02
Drugs
oxybutynin
03
Conditions
hyperhidrosismajor depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT201101045547N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201101045547N1.